0001358403-16-000294.txt : 20161129
0001358403-16-000294.hdr.sgml : 20161129
20161129160510
ACCESSION NUMBER: 0001358403-16-000294
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161125
FILED AS OF DATE: 20161129
DATE AS OF CHANGE: 20161129
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Musso Alan A
CENTRAL INDEX KEY: 0001295830
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 162022800
MAIL ADDRESS:
STREET 1: C/O TARGACEPT, INC.
STREET 2: 200 EAST FIRST STREET, SUITE 300
CITY: WINSTON-SALEM
STATE: NC
ZIP: 27101
4
1
wf-form4_148045349793060.xml
FORM 4
X0306
4
2016-11-25
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001295830
Musso Alan A
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
0
1
0
0
CFO and Treasurer
Common Stock
2016-11-25
4
S
0
6273
20.4815
D
83575
D
Common Stock
2016-11-28
4
S
0
22427
19.2292
D
61148
D
Common Stock
2016-11-28
4
S
0
600
19.845
D
60548
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person on December 22, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.23 to $20.69. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Includes 665 shares acquired under the Issuer's Employee Stock Purchase Plan, the "ESPP" on June 10, 2016; and 441 shares acquired under the ESPP on December 10, 2015.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.71 to $19.6826. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.72 to $20.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ Alan A. Musso
2016-11-29